E-DRUG Archives (by date)

• Thread Index

September 30, 2003
• [e-drug] UN session tackling African pandemic (cont'd)
  • From: Elizabeth Gardiner <egardiner.sln2003@london.edu>
• [e-drug] 2nd Announcement - PRDU Course, Lahore, Pakistan
  • From: Azhar Hussain <azhar@thenetwork.org.pk>
September 29, 2003
• [e-drug] UN session tackling African pandemic (cont'd)
  • From: Valeria Frighi <valeria.frighi@dtu.ox.ac.uk>
September 26, 2003
• [e-drug] New FIP statements available online
  • From: Satu Tainio <satu@fip.org>
• [e-drug] Malaria: the terrorist's friend
  • From: e-drug@healthnet.org
• [e-drug] Promoting Rational Drug Use Course, Nairobi, Kenya (cont'd)
  • From: John Chalker <jchalker@msh.org>
September 25, 2003
• [e-drug] HAI Fact Sheet Global Fund Requirements
  • From: HAI Africa <haiafrica@africaonline.co.ke>
September 24, 2003
• [e-drug] WHO Model List of Essential Medicines
  • From: Hans Hogerzeil <hogerzeilh@who.int>
• [e-drug] One World Health and DNDi (cont'd)
  • From: Jaya Bannerji <jaya.banerji@geneva.msf.org>
September 23, 2003
• [e-drug] UN session tackling African pandemic seeks to aid access
  • From: Leela McCullough <leela@healthnet.org>
• [e-drug] WHO Declaration of Global Health Emergency
  • From: Leela McCullough <leela@healthnet.org>
• [e-drug] Nifedipine deletion WHO Essential medicines List
  • From: Valeria Frighi <valeria.frighi@dtu.ox.ac.uk>
September 22, 2003
• [e-drug] Research in Hospital Drug Use (cont'd)
  • From: Richard Laing <laingr@who.int>
• [e-drug] WHO EDL Committee 2004 and proposed deletions (cont'd)
  • From: Bernard van de Wal <bwvdewal@sun.ac.za>
• [e-drug] Drug pricing and affordability
  • From: Zaheer-Ud-din Baber <zaheerb@sedaya.edu.my>
September 19, 2003
• [e-drug] A bad week for drug companies?
  • From: e-drug@healthnet.org
• [e-drug] WHO EDL Committee 2004 and proposed deletions (cont'd)
  • From: Ric Day <R.Day@unsw.edu.au>
September 18, 2003
• [e-drug] Methyl xanthenes to be deleted from 13th Model EML 2003
  • From: Norman Olson <nolsonmd@aol.com>
• [e-drug] WHO EDL Committee 2004 and proposed deletions
  • From: e-drug@healthnet.org
• [e-drug] 118 essential medicines missing on the market: Survey
  • From: Azhar Hussain <azhar@thenetwork.org.pk>
• [e-drug] OneWorld Health and DNDI
  • From: Philippe Swennen <philippe.swennen@aim-mutual.org>
• [e-drug] Guidelines for drug disposal (cont'd)
  • From: Stevan Gressitt <gressitt@uninets.net>
September 17, 2003
• [e-drug] Forbes article on OneWorld Health
  • From: Michael MacHarg <mmacharg@oneworldhealth.org>
• [e-drug] Nifedipine deletion from 13th Model Essential Drug List
  • From: Norman Olson <nolsonmd@aol.com>
• [e-drug] Hydralazine deletion from 13th Model Essential Drug List
  • From: Norman Olson <nolsonmd@aol.com>
• [e-drug] World's first nonprofit drug company launched (cont'd)
  • From: "S. Srinivasan" <sahajbrc@icenet.net>
September 16, 2003
• [e-drug] World's first nonprofit drug company launched
  • From: e-drug@healthnet.org
September 14, 2003
• [e-drug] Guidelines for drug disposal (cont'd)
  • From: James Russo <JBRusso@aol.com>
• [e-drug] Drug interactions service
  • From: Horst Herb <subscriptions@gnumed.net>
• [e-drug] Guidelines for drug disposal
  • From: Mona Hussein <pharmacia66@yahoo.com>
September 13, 2003
• [e-drug] BMJ editorial on WTO/TRIPS Medicines
  • From: e-drug@healthnet.org
September 12, 2003
• [e-drug] Unintended ARV treatment interruptions (cont'd)
  • From: Chris Green <chrisg@rad.net.id>
• [e-drug] Research in Rational Drug Use
  • From: "G.B. Simpson" <dicindia@yahoo.co.in>
September 10, 2003
• [e-drug] Unintended ARV treatment interruptions (cont'd)
  • From: Beverley Snell <bev@burnet.edu.au>
• [e-drug] Dispensing Doctors Monitor article (cont'd)
  • From: Richard Parrish <RParrish@su.edu>
• [e-drug] Dispensing Doctors Monitor article (cont'd)
  • From: Birna Trap <btrap@ehg.dk>
September 09, 2003
• [e-drug] FDA Anti-Counterfeit Drug Meeting
  • From: E-drug <e-drug@healthnet.org>
• [e-drug] Unintended ARV treatment interruptions (cont'd)
  • From: Jude Ike Nwokike <monkiyke@yahoo.com>
• [e-drug] Unintended ARV treatment interruptions (cont'd)
  • From: Murtada Sesay <msesay@unicef.org>
September 08, 2003
• [e-drug] Unintended ARV treatment interruptions
  • From: Fionnuala Mc Cullagh <fionnualamccullagh@hotmail.com>
September 07, 2003
• [e-drug] Ensuring ethical drug promotion (cont'd)
  • From: Alfred Sackeyfio <Awnsack@aol.com>
September 06, 2003
• [e-drug] Two new documents on affordability and financing of ACTs
  • From: Hilbrand Haak <haakh@chd-consultants.nl>
September 05, 2003
• [e-drug] Revision on US and Brazilian ARV Price comparison
  • From: James Love <james.love@cptech.org>
• [e-drug] WHO/AFRO: Medicines and hospitals in Africa
  • From: Leela McCullough <leela@healthnet.org>
• [e-drug] Brazil and US ARV prices compared
  • From: James Love <james.love@cptech.org>
September 04, 2003
• [e-drug] Worries about acceptance of MMR (cont'd)
  • From: Letitia Toms <letitia.toms@health.gov.au>
• [e-drug] DTCA and Canada 3
  • From: e-drug@healthnet.org
• [e-drug] DTCA and Canada 2
  • From: e-drug@healthnet.org
• [e-drug] DTCA and Canada 1
  • From: e-drug@healthnet.org
September 03, 2003
• [e-drug] Ensuring ethical drug promotion (cont'd)
  • From: Richard Parrish <RParrish@su.edu>
• [e-drug] Africans Outdo Americans in Following AIDS Therapy
  • From: e-drug@healthnet.org
• [e-drug] MSF Documents on FTAA and TRIPS
  • From: Rachel Cohen <Rachel.Cohen@newyork.msf.org>
• [e-drug] Ensuring ethical drug promotion (cont'd)
  • From: Lee Richardson <caroleejam@comcast.net>
• [e-drug] WHO and ARV access (cont'd)
  • From: Bonface Fundafunda <bfundafunda@unicef.org>
• [e-drug] Dispensing Doctors Monitor article (cont'd)
  • From: Bonface Fundafunda <bfundafunda@unicef.org>
• [e-drug] Worries about acceptance of MMR
  • From: Peter Copp <petercopp@gpplus.co.uk>
• [e-drug] Ensuring ethical drug promotion (cont'd)
  • From: Murtada Sesay <msesay@unicef.org>
September 02, 2003
• [e-drug] Ensuring ethical drug promotion (cont'd)
  • From: Jude Nwokike <monkiyke@yahoo.com>
• [e-drug] Dispensing Doctors Monitor article
  • From: Richard Laing <laingr@who.int>
• [e-drug] Ensuring ethical drug promotion--whose responsibility? (cont'd)
  • From: "Barbara Mintzes" <bmintzes@telus.net>
• [e-drug] Ensuring ethical drug promotion--whose responsibility? (cont'd)
  • From: pierre chirac <pierchir@club-internet.fr>
• [e-drug] WHO/AFRO report 2002 on essential medicines
  • From: e-drug@healthnet.org
• [e-drug] WHO and ARV access (cont'd)
  • From: maija.palander@fimnet.fi
September 01, 2003
• [e-drug] Ensuring ethical drug promotion--whose responsibility?
  • From: e-drug@healthnet.org